ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206 | -77.8% | 34,018 | -71.5% | 0.02% | -80.6% |
| Q2 2023 | $927 | +14.2% | 119,490 | -16.1% | 0.09% | +16.2% |
| Q1 2023 | $812 | -42.2% | 142,405 | -40.3% | 0.08% | -54.0% |
| Q4 2022 | $1,404 | -99.8% | 238,359 | +5.7% | 0.17% | +81.2% |
| Q3 2022 | $722,000 | +218.1% | 225,600 | +345.5% | 0.10% | +182.4% |
| Q2 2022 | $227,000 | 0.0% | 50,635 | +19.1% | 0.03% | +13.3% |
| Q1 2022 | $227,000 | -35.5% | 42,507 | +77.5% | 0.03% | -31.8% |
| Q4 2021 | $352,000 | – | 23,954 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |